MoneyWorks4Me

Indoco Remedies informs about transcript of earnings call

26 May 2023 Evaluate

Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Indoco Remedies has informed that it enclosed the transcript of Earnings Conference Call held on 23rd May, 2023 in respect of Audited Standalone and Consolidated Financial Results for the quarter and year ended 31st March, 2023.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1756.90
Dr. Reddys Labs. 1195.10
Cipla 1303.30
Lupin 1960.00
Zydus Lifesciences 1115.10
View more..